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A B S T R A C T
Background: Cervical cancer is a global burden, with increasing incidence and mortality especially in developing countries where 
there are no clearly define national protocols or guidelines for effective screening and prompt treatment of cervical dysplasia 
(precancerous condition of the cervix). Most screening facilities are located in the tertiary hospitals, which are mostly not readily 
accessible to patients because of fear and bureaucracy of accessing services at these tertiary hospitals. In Nigeria, cervical cancer 
is the second most common female malignancy after breast cancer and national guidelines on effective screening is not readily 
available. At the general outpatients’ Clinic, University College Hospital, Ibadan, screening is not well‑established and patients are 
referred to the gynecology clinic for papanicolaou (Pap) smear, which result in poor compliance as a result of the protocol involved. 
Aim: To asess the prevalence and risk factors for abnormal cervical cancer screening  amongst patients of the Primary Care Clinic 
at UCH, Ibadan, towards justifying expansion of cervical cancer screening service points in tertiary health institutions in Nigeria. 
Subjects and Methods: A cross‑sectional study using the self‑administered structured questionnaire on questions relating to the 
socio‑demographic characteristics and lifestyle behavior including sexual history, after which Pap smear and visual inspection of 
the cervix with acetic acid were performed. Two hundred and eighty consented women aged 20–65 years were interviewed by one 
of the researchers between June and August 2012 using interviewer‑administered structured questionnaires. The questionnaire 
sought information on their sociodemographic characteristics, and lifestyle behavior including sexual history, after which Pap 
smear and visual inspection of the cervix with acetic acid were done, respectively, for all the respondents at no cost. The results 
were analyzed using Statistical Package for Social Sciences (SPSS) version 11. Cross‑tabulation was used to explore statistical 
associations between categorical variables. Variables were summarized using frequency distribution, means, proportions, and 
findings were presented in tables, histograms and pie charts. Chi‑square statistic was used to assess the association between 
categorical variables. The level of significance was set at P < 0.05. Result: The mean age of the women was 42.5 (11.1) years, and their 
modal age was 30–39 years. The majority, 92.2% (258/280) of the women were Yoruba. Two hundred and twenty‑eight (81.4%) of 
the women were married with majority 149 (65.4%) in the monogamous union. Two hundred and thirteen (76.1%) of the women had 
abnormal cervical cytology. One hundred and sixty‑six (77.9%) of the women with abnormal cytology had inflammatory smears, 33 
(15.5%) and 6 (2.8%) had mild and moderate dysplasia, respectively, while the remaining 8 (3.8%) had atypical cells. The prevalence of 
cervical dysplasia among all the women was 13.9% (39/280), with mild dysplasia accounting for 11.8% (33/280) of the total population. 
Atypical smears were found in 2.9% (8/280) of them. Histological findings suggestive of human papillomavirus (HPV) were found in 
22 of the 33 (66.7%) women who had mild dysplasia and 1 of the 6 (16.7%) women who had moderate dysplasia. There was significant 
association between abnormal cervical cytology and age (P = 0.03), as well as suggested HPV infection findings (P < 0.001). Visual 
inspection of the cervix with 5% acetic acid revealed that 46 of the 280 (16.4%) women had an aceto white area, while a prevalence 
of 47 (16.8%) was found with Pap smear, though visual inspection was found not to be as sensitive in detecting dysplasia. The 
prevalence of cervical dysplasia among the women was 13.9%, with mild dysplasia accounting for 11.8% of the total population. 
Atypical smears were found in 2.9% of them. There was a significant association between abnormal cervical cytology and increasing 
age (P = 0.03), as well as histological findings of HPV infection (P < 0.001). Conclusion: Cervical dysplasia was found to be a common 
health problem among women attending the primary care clinic. This underscores the need for the provision of screening service 
at the clinic and effective health education to promote preventive practices and inculcate screening culture among women.
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INTRODUCTION
Cervical dysplasia is a disordered growth of the epithelial lining 
of the cervix.[1] It is the precancerous condition of the cervix 
which may progress to cervical cancer over a period of time, 
in an average of 10–15 years.[2,3] Cervical dysplasia especially 
the low-grade lesion regresses spontaneously in a significant 
number of patients, allowing for expectant management with 
serial cytologic smears, whereas the high-grade lesions will 
progress to an invasive cancer if left untreated.[2,3]
The prevalence of cervical dysplasia varies according to the 
socioeconomic characteristics and geographic area of the 
population studied, from as low as 1.05% in some family 
planning clinics to as high as 13.7% in women attending 
sexually transmitted disease (STD) clinics.[1] Prevalence rates of 
9.3% and 12% were found among the women screened in STD 
and family planning clinics of the University College Hospital 
(UCH), Ibadan respectively.[4,5] Cervical dysplasia is mostly 
detected in women in their 20th year, the peak incidence of 
carcinoma in situ being in women aged 25–35 years, while the 
incidence of cervical cancer rises after the age of 40 years.[1]
Cervical cancer is a global burden, and it is the most common 
cause of preventable cancer-related death especially in 
developing countries like Nigeria.[2,3] The incidence of 
cervical cancer has reduced remarkably in developed 
countries where there are effective, well-coordinated 
screening programs, and prompt treatment of cervical 
dysplasia. However, this incidence has been on the increase 
and has constituted major health problems among women 
in developing countries where there are no well-coordinated 
and effective screening programs.
There have been a lot of postulations about the predisposing 
factors for developing cervical cancer. It has been established 
to be a sexually transmitted infection, since it is commonly 
found in women who have had human papillomavirus (HPV) 
infection[3,6-9] and in those with multiple sexual partners or 
those whose spouses have multiple sexual partners. It has 
also been linked with human immunodeficiency virus,[10] 
poverty,[11] cigarette smoking,[8] multiparity, and use of oral 
contraceptive pills, especially when it was used for more 
than 12 years.[12]
Cervical cancer screening is an important component of the 
World Health Organization (WHO) strategy for combating 
cancer.[2,13] Available evidences indicate that cervical cancer 
screening programs have been effective in developed 
countries where a significant reduction in the incidence of and 
mortality from cervical cancer have been observed over the last 
three decades.[14] The WHO recommends that in low-income 
countries every woman should be screened at least once in 
her lifetime between the ages of 35 and 40 years.[2,13] The 
cost effectiveness of this is greater in countries with higher 
rates of cervical cancer and those with identifiable high-risk 
groups.[2,13] Even where effective screening programs exist, 
there is ignorance of such.[2,5,13,14] The WHO recommendation, 
therefore, is for the development of national cancer strategies 
based on surveillance and prevention programs tailored to 
local needs.[13] However, an organized screening program 
is difficult to implement in developing countries where 
resources are scarce.[2,3] There are few if any, cytological 
screening programs in most developing countries, including 
Nigeria and coverage is insufficient to have an impact.[6,15,16] 
In these countries, screening is mostly done in the context 
of opportunistic activities, which are often inadequately 
performed.[3,15,16] It is estimated that some 40–50% of women 
in developed countries have been screened for cervical 
dysplasia by the year 1988 compared to 5% of women in 
developing countries.[2,3,14] In Nigeria, where most women are 
uneducated and stay in rural areas, and physicians are few, 
this poses a further significant limitation.
Cytological screening for the detection of precancerous 
diseases of the cervix has been the most successful of the 
public health measures introduced for the prevention of 
cervical cancer, though it is expensive and requires the services 
of a cytopathologist or cytotechnologist.[2,14,17] Cytological 
screening entails the use of papanicolaou smear to identify 
abnormal cells on the transformation zone of the cervix.
Human papillomavirus is a member of the family of DNA 
tumor viruses and can also colonize mucosa or cutaneous 
epithelium to induce hyperproliferation.[18] HPV cytologic 
changes are included in the terminology of the Bethesda 
classification system for cervical cytology as koilocytosis. 
However, the other pathognomonic changes attributed to 
HPV do not alone define those patients who could develop 
cervical cancer later.[18] Most individuals with these HPV 
changes never develop either in situ or invasive carcinoma, 
but undergo spontaneous regression within 1-year in 63.6% 
of the low-grade squamous intraepithelial lesion and 38.2% 
of the high-grade squamous intraepithelial lesion.[18-20]
National consultations on cervical cancer control have, 
however, concurred that cytology-based screening 
programs are not feasible in most developing countries 
in many years to come in view of technical, financial, and 
manpower constraints.[21] Screening programs for cervical 
cancer have thus consistently failed to meet the target 
population due to this lack of manpower and funds.[2,22,23]
The current WHO recommendation is to propagate visual 
inspection of the cervix with 5% acetic acid (VIA) or visual 
inspection with Lugol’s iodine (VILI), as potential alternatives 
to cytology and to identify early curable cancer.[21,16,24] 
A preventive strategy is more constructive, but screening 
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by cytology is found to be too complex and more expensive. 
Considering the number of women that would need cervical 
cancer screening services in most tertiary hospitals and 
fewer cytopathologists, there is need to have VIA or VILI 
screening facilities available at all levels of care.[25,26]
The primary health physicians being the first contact Doctors, 
need to offer preventive and promotive health care to 
patients after attending to their immediate health needs.[25,26] 
These first contact physicians are in a better position to offer 
effective screening for cervical dysplasia at all health care 
levels, especially at primary and secondary care levels, for early 
detection, prompt treatment of moderate/severe dysplasia and 
appropriate referral when the need arises.[26] This is necessary 
to make the screening accessible, available, and affordable to 
all women irrespective of their socioeconomic status and the 
time available to them to attend a health facility.
At the general outpatients’ (GOP) Clinic, UCH, Ibadan, 
Nigeria screening is not well-established, and patients 
are referred to Gynecology clinic for papanicolaou (Pap) 
smear. The protocol involved in getting Pap smear done is 
cumbersome, and this results into poor compliance. This 
may underscore the need for functional cervical cancer 
screening service at all the GOP Clinics in order to increase 
coverage and uptake of this service.
This study was carried out to determine
To determine the prevalence of abnormal cervical cytology 
among women attending the GOP Clinic, sociodemographic 
and family characteristics of women with abnormal cervical 
cytology results and identify risk factors associated with 
abnormal cervical cytology among women screened.
SUBJECTS AND METHODS
This hospital-based cross-sectional descriptive study was 
conducted at the UCH in Ibadan, South-Western Nigeria 
between June 1st and August 31st 2012. Two hundred and 
eighty consented consecutive women aged 20–65 years 
participated in the study. Institutional ethical approval 
was obtained for the study. This study has attempted to 
determine the prevalence of abnormal cervical cytology and 
possible associated risk factors among women aged 20–65 
years in our environment.
Inclusion criteria
All consenting women aged 20–65 years who presented at 
the clinic during the study period.
Exclusion criteria
Those who refused to give consent to participate, or the 
presence of symptoms and signs of carcinoma of the cervix 
or critically ill women.
Data collection
Structured questionnaires were developed by all the 
authors and administered to 280 consecutive women by 
the researchers. The questionnaire sought information 
on their sociodemographic characteristics and lifestyle 
behavior including sexual history. Physical examination, 
Pap smear, and visual inspection with 5% acetic acid were 
carried out in the consulting rooms by the researchers 
(OAM, IOA, AEI), who are all of consultant family physician 
cadre. A prestudy training and harmonization of sampling 
methods was conducted for researchers by AAO (consultant 
gynecological oncologist). Slides were processed and 
reported at the pathology department of the hospital by 
both AOO and EEUA. The result of the visual inspection 
was relayed to the women immediately while they were 
asked to come back in 4 weeks for the results of the 
Papanicolaou smear.
All patients with abnormal results beyond infection/
inflammatory findings were referred to the gynecological 
clinic of the hospital for specialist treatment.
Sample size calculation
The sample size was determined using prevalence of 
cervical dysplasia in a previous study done in Gynaecology 
Clinic, UCH, Ibadan.[5] The sample size was calculated using 
the following formula.[29]
N = Z2P (1−P)/D2
Where,
N = Minimum sample size.
P = The prevalence value of 12% of dysplasia in a study done 
in UCH, Ibadan in 1999.[5]
D = The absolute precision of the study which is 0.04.
Z = Area under normal curve corresponding to 95% 
confidence interval = 1.96.
Therefore the sample size was calculated as 254
With correction for 10% nonresponse, it is approximated to 
280.
The results were analyzed using Statistical Package for 
Social Sciences (SPSS) version 11 software (SPSS Inc., 
Chicago, IL, USA). Cross-tabulation was used to explore 
statistical associations between categorical variables. 
Variables were summarized using frequency distribution, 
means, proportions, and findings were presented in tables, 
histograms, and pie charts. Chi-square statistic was used to 
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assess the association between categorical variables. The 
level of significance was set at P < 0.05.
Procedure for screening (papanicolaou smear 
and visual inspection of the cervix with acetic 
acid)
Papanicolaou smear
The patients were laid in lithotomy position, the cervix 
was exposed using the Cusco’s speculum, Ayre’s spatula 
was used to take the specimen from the ectocervix and 
the cytobrush to take the specimen from the endocervix. 
These were used to make a smear on the labeled slides; 
the slides were immediately fixed by spraying it with 95% 
ethanol before leaving it to dry. The slides were sent to the 
pathology laboratory of UCH for staining with Pap dye and 
thereafter examined by the Pathologists.
Visual inspection of the cervix with acetic acid
Visual inspection with acetic acid involves naked eye 
examination of the 5% acetic acid swabbed cervix with 
illumination provided by a bright light source. Five percent 
acetic acid was daily freshly prepared before use. It was 
prepared from 100% acetic acid by diluting 1 ml of 100% 
acetic acid with 19 ml of distilled water. The freshly 
prepared 5% acetic acid was used to swab the cervix after it 
was fully exposed with a Cusco’s speculum. The cervix was 
then examined with a good light source, for aceto white 
area, within a minute of application of the acetic acid.
The objective of VIA is to be able to recognize clinically 
normal (acetic acid test negative) from abnormal cervix 
(acetic acid test positive) and refer abnormal cases for further 
evaluation, diagnosis, and appropriate treatment.[27,28]
The aim of VIA is to detect and treat cervical dysplasia in 
asymptomatic women, to prevent the development of 
cervical cancer and to complement Pap smear screening 
where the facility is available.
The results of the visual inspection of the cervix with acetic 
acid are interpreted as follows
Visual inspection of the cervix with acetic acid test negative 
(no aceto - white area): Follow-up in 3–5 years.
Visual inspection of the cervix with acetic acid test positive 
(aceto-white area(s) present): If due to infection, microscopy 
and culture were done and appropriate treatment instituted. 
Patient was re-examined after 6 weeks.
RESULT
The mean (standard deviation [SD]) age of the women was 
42.5 (11.1) years; the modal age group was 30–39 years. 
Majority 258 of 280 (92.2%) of the women were from the 
Yoruba ethnic group. Two hundred and twenty-eight (228) 
of 280 (81.4%) of the women were married with majority 
149 of 280 (65.4%) in monogamous union [Table 1].
Two hundred and thirteen (76.1%) women had abnormal 
smears, of which 166 (59.3%) had Inflammatory smears, 33 
(11.8%) mild dysplasia, 6 (2.1%) moderate dysplasia, and 8 
(2.9%) atypical cells. The prevalence of cervical dysplasia 
among the women screened was 13.9% [Figure 1].
The mean age (SD) of women with abnormal smear was 43.6 
(11.0) years; the modal age group was 40–49 years. The 
majority (76.0%) of the 258 respondents from the Yoruba 
ethnic group and 10 (76.9%) of the 13 Igbo women had 
abnormal cervical smears. One hundred and seventy-four 
(81.7%) of the women who had abnormal smear were 
married, with majority 111 (52.1%) in a monogamous 
setting, while the remaining 63 (29.6%) were in polygamous 
homes. Fifty-three (24.9%) of the women with abnormal 
smear attained tertiary education, while 38 (17.8%) had no 
formal education. The majority of women with abnormal 
smears, 145 (68.1%) were above poverty line while the 
remaining 68 (31.9%) were below poverty line [Table 2].
Age was found to be significantly associated with abnormal 
smear with P = 0.03, abnormal cervical smear was more 
in women who were 40 years and above [Table 2]. The 
prevalence of dysplasia 33 (38.8%) and 4 (5.0%) were found 
among women who were married with most of them in 
polygamous union though not statistically significant 
[Table 3]. The prevalence of inflammatory smear increased 
with increasing number of children per women from 11 
(57.9%) in those who had no child to 73 (83.9%) in those 
who had 5 or more children. Moderate dysplasia increased 
from 2 (3.0%) in those who had 3–4 children to 4 (4.6%) in 
those who had more than 5 children whilst, mild dysplasia 




















Figure 1: Categorization of cervical cytology into specific diagnostic 
groups
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[Table 3]. The prevalence of inflammatory smears decreased 
with increasing number of sexual partners except in women 
having 5 or more sexual partners. However, dysplasia and 
atypical cells were associated with increased number of 
sexual partners, but this was not statistically significant. 
Inflammatory smears were slightly more 47 (78.3%) in those 
who had sexual intercourse before the age of 18 years than 
those who had sexual intercourse after the age of 18 years 
119 (77.8%) [Table 4]. Thirteen (21.7%) of the women who 
had first sexual intercourse before the age of 18 years had 
dysplasia and atypical cells while 34 (22.3%) of those who 
had first sexual intercourse after the age of 18 years had 
dysplasia and atypical cells. Significantly, 23 (100%) of the 
women who had histological finding of HPV (koilocytes) had 
dysplasia while, 16/190 (8.4%) of those who were negative 
had dysplasia. The prevalence of dysplasia and atypical 
cells was found to be more among women who used oral 
contraceptive 18/72 (25.0%) than those who did not use Table 2: Comparison of the sociodemographic characteristics 








Age groups in years
20‑29 17 (25.4) 22 (10.3) 39 (13.9)
30‑39 20 (29.8) 58 (27.2) 78 (27.9)
40‑49 14 (20.9) 62 (29.1) 76 (27.1)
50‑59 14 (20.9) 47 (22.1) 61 (21.8)
≥65 2 (3.0) 24 (11.3) 26 (9.3)
χ2=13.472, df=4, P=0.01*
Ethnic groups
Yoruba 62 (92.5) 196 (92.0) 258 (92.1)
Igbo 3 (4.5) 10 (4.7) 13 (4.7)
Hausa 0 (0.0) 2 (0.9) 2 (0.7)
Others 2 (3.0) 5 (2.4) 7 (2.5)
χ2=0.719, df=3, P=0.87
Marital status  
Single 7 (10.7) 12 (5.6) 19 (6.8)
Married monogamous 38 (56.7) 111 (52.1) 149 (53.2)
Married polygamous 16 (23.9) 63 (29.6) 79 (28.3)
Divorced/separated 2 (3.0) 11 (5.2) 13 (4.6)
Widowed 4 (6.0) 16 (7.5) 20 (7.1)
χ2=3.221, df=4, P=0.52
Educational status
No formal education 5 (7.5) 38 (17.8) 43 (15.4)
Primary school completed 13 (19.4) 41 (19.2) 54 (19.2)
Secondary school uncompleted 5 (7.5) 26 (12.2) 31 (11.1)
Secondary school completed 12 (17.9) 55 (25.8) 67 (23.9)
Tertiary 32 (47.8) 53 (24.9) 85 (30.4)
χ2=14.732, df=4, P=0.01*
Social class
I 9 (13.4) 33 (15.5) 42 (15.0)
II 9 (13.4) 22 (10.3) 31 (11.1)
III 15 (22.4) 51 (23.9) 66 (23.6)
IV 22 (32.8) 79 (37.1) 101 (36.1)
V 12 (17.9) 28 (13.2) 40 (14.2)
χ2=1.706, df=4, P=0.79
Income
Below the poverty line 17 (25.4) 68 (31.9) 85 (30.4)
Above the poverty line 50 (74.6) 145 (68.1) 195 (69.6)
χ2=1.035, df=1, P=0.31
Stevenson’s family stages
Emerging family 22 (32.8) 50 (23.5) 72 (25.7)
Crystallizing family 24 (35.8) 67 (31.5) 91 (32.5)
Interacting family 17 (25.4) 77 (36.2) 94 (33.6)
Actualizing family 4 (6.0) 19 (8.9) 23 (8.2)
χ2=4.339, df=3, P=0.23
*Significant at 5% level
oral contraceptive 20.6% (29/141). There was a significant 
association between cervical dysplasia and age (P = 0.03), 
as well as histological findings suggestive of HPV infection 
(koilocytes) (P < 0.001). Koilocytes were found in 22 (66.7%) 
of the 33 women who had mild dysplasia and 1 (16.7%) of the 
6 women who had moderate dysplasia [Table 4].
Table 5 displays the association between VIA and cytology. 
Acetowhite reaction was demonstrated in only 5 (12.8%) 
of the 39 women who had dysplasia, 26 (15.7%) of the 166 
women who had inflammatory smears. None of the 8 women 
who had atypical smears had aceto white area. Aceto white 
reaction was seen in 15 (22.4%) of the 67 women who had 
normal smears (that is false positive results). There was 
significant number of false negative results. This is explained 
as follows: 140 (84.3%) of the 166 women with inflammatory 
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smears were false negative, 29 (87.9%) of 33 women with mild 
dysplasia were false negative, whilst 5 (83.3%) of 6 women 
with moderate dysplasia were also false negative results.
Visual inspection of the cervix with 5% acetic acid revealed 
that 46 (16.4%) of the 280 women had an acetowhite area 
[Table 6]. The sensitivity and specificity of VIA using cytology 
as the gold standard in this study were 10.6% and 82.4%, 
respectively [Figure 2].
DISCUSSION
Two hundred and thirteen (76.1%) of the studied women 
had abnormal cervical cytology, with the majority 166 
(59.3%) having inflammatory smears. Thirty-nine (13.9%) had 
dysplasia (mild and moderate), while 8 (2.9%) had atypical 
cervical smears. Inflammatory changes are relatively 
frequent findings in cervical smears and are generally 
believed to be a consequence of genital infection.[30,31] 
However, clinical signs of infection are frequently absent, 
and no consensus exists on the management of these 
women.[30] The presence of inflammatory cells on cervical 
smears is not necessarily due to infection.[30] It could 
be due to reactive or reparative cellular changes of the 
cervix following injury, radiation, intrauterine devices or 
atrophy.[30,32] Webb et al. in 2001, however, found that 
there was no significant difference in the resolution of 
cytologic inflammatory changes after treatment with 
antibiotics.[33]
Parashari et al. in Maulana Azad Medical College, New Delhi, 
India in 1995 found that a large proportion of women with 
Table 3: Comparison of prevalence of different types of abnormal cervical cytology with the sociodemographic characteristics of 
the respondents
Inflammatory (n=166) (%) Mild dysplasia (n=33) (%) Moderate dysplasia (n=6) (%) Atypical (n=8) (%) Total (n=213) (%)
Age groups in years
20‑29 16 (72.7) 5 (22.7) 0 (0.0) 1 (4.6) 22 (10.3)
30‑39 40 (69.0) 14 (24.1) 1 (1.7) 3 (5.2) 58 (27.2)
40‑49 48 (77.4) 9 (14.5) 4 (6.5) 1 (1.6) 62 (29.1)
50‑59 41 (87.2) 4 (8.5) 0 (0.0) 2 (4.3) 47 (22.1)
≥65 21 (87.5) 1 (4.2) 1 (4.2) 1 (4.2) 24 (11.3)
χ2=28.757, df=16, P=0.03*
Marital status
Single 7 (58.3) 4 (33.3) 0 (0.0) 1 (8.3) 12 (5.6)
Married monogamous 89 (80.2) 17 (15.3) 3 (2.7) 2 (1.8) 111 (52.1)
Married polygamous 48 (76.2) 10 (15.9) 3 (4.8) 2 (3.2) 63 (29.6)
Divorced/separated 8 (72.7) 1 (9.1) 0 (0.0) 2 (18.2) 11 (5.2)
Widowed 14 (87.5) 1 (6.3) 0 (0.0) 1 (6.3) 16 (7.5)
χ2=14.725, df=12, P=0.26
Educational level
No formal education 31 (81.6) 4 (10.5) 2 (5.3) 1 (2.6) 38 (17.8)
Primary school completed 32 (78.0) 8 (19.5) 1 (2.4) 0 (0.0) 41 (19.2)
Secondary school uncompleted 20 (76.9) 4 (15.4) 0 (0.0) 2 (7.7) 26 (12.3)
Secondary school completed 44 (80.0) 6 (10.9) 2 (3.6) 3 (5.5) 55 (25.8)
Tertiary education 39 (73.6) 11 (20.8) 1 (1.9) 2 (3.8) 53 (24.9)
χ2=7.970, df=12, P=0.79
Social class
I 26 (78.8) 4 (12.1) 1 (3.0) 2 (6.1) 33 (15.5)
II 21 (95.5) 1 (4.5) 0 (0.0) 0 (0.0) 22 (10.3)
III 34 (66.7) 13 (25.5) 2 (3.9) 2 (3.9) 51 (23.9)
IV 64 (81.0) 11 (13.9) 3 (3.8) 1 (1.3) 79 (37.1)
V 21 (75.0) 4 (14.3) 0 (0.0) 3 (10.7) 28 (13.2)
χ2=15.328, df=12, P=0.22
Parity
0 11 (57.9) 7 (36.8) 0 (0.0) 1 (5.3) 19 (8.9)
1‑2 33 (82.5) 5 (12.5) 0 (0.0) 2 (5.0) 40 (18.8)
3‑4 49 (73.1) 12 (17.9) 2 (3.0) 4 (6.0) 67 (31.5)
5 or more 73 (83.9) 9 (10.3) 4 (4.6) 1 (1.1) 87 (40.8)
χ2=14.621, df=9, P=0.10
*Significant at 5% level
83.6%
16.4%
Negative acetowhite Positive acetowhite
Figure 2: Prevalence of acetowhite lesion with 5% acetic acid
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inflammatory smears had multiple gynecological infections 
and may be at risk of developing precancerous or cancerous 
changes.[34] They found 8 (72.7%) of 11 women who had dysplasia 
detected by colposcopy and confirmed by biopsy actually had 
inflammatory cytology in initial Pap smears.[35] Similar findings 
had also been reported by Younglove and Newman in 1978, 
when they discovered the prevalence of dysplasia as 36% 
among women with inflammatory smear after colposcopy 
and biopsy.[35] It is therefore better to consider inflammatory 
cervical cytology smear as being abnormal smears because it 
could mask the dysplastic cells giving a false negative result, 
hence the importance of treating women with inflammatory 
smears and repeating the test within 3–6 months of treatment.
The prevalence of cervical dysplasia was found to be 13.9% 
in this study which is marginally more than prevalence of 
12.0% found by Ayinde et al. in 1998 when they studied 
women accessing Pap smear through family planning 
Table 4: Prevalence of different types of abnormal cervical cytology with lifestyle of the respondents
Inflammatory (n=166) (%) Mild dysplasia (n=33) (%) Moderate dysplasia (n=6) (%) Atypical (n=8) (%) Total (n=213) (%)
Number of sexual partners
1 75 (81.5) 13 (14.1) 2 (2.2) 2 (2.2) 92 (43.2)
2 46 (75.4) 11 (18.0) 2 (3.3) 2 (3.3) 61 (28.6)
3 24 (72.7) 6 (18.2) 0 (0.0) 3 (9.1) 33 (15.5)
4 14 (70.0) 3 (15.0) 2 (10.0) 1 (5.0) 20 (9.3)
≥5 7 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 7 (3.4)
χ2=10.989, df=12, P=0.53
Coitache
Before 18 years of age 47 (78.3) 9 (15.0) 3 (5.0) 1 (1.7) 60 (28.2)
After 18 years of age 119 (77.8) 24 (15.7) 3 (2.0) 7 (4.6) 153 (71.8)
χ2=2.399, df=3, P=0.49
Koilocytes (suggestive of HPV)
Positive 0 (0.0) 22 (95.7) 1 (4.3) 0 (0.0) 23 (10.8)
Negative 166 (87.4) 11 (5.8) 5 (2.6) 8 (4.2) 190 (89.2)
χ2=128.214, df=3, P<0.001*
Use of oral contraceptives
Yes 54 (75.0) 11 (15.3) 4 (5.5) 3 (4.2) 72 (33.8)
No 112 (79.4) 22 (15.6) 2 (1.4) 5 (3.6) 141 (66.2)
χ2=3.162, df=3, P=0.37
Years of oral contraceptive use
Less than 12 years of use 48 (73.8) 10 (15.4) 4 (6.2) 3 (4.6) 65 (90.3)
More than 12 years of use 7 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 7 (9.7)
Family history of cervical cancer
Yes 3 (75.0) 0 (0.0) 0 (0.0) 1 (25.0) 4 (1.9)
No 163 (78.0) 33 (15.8) 6 (2.9) 7 (3.3) 209 (98.1)
χ2=5.649, df=3, P=0.13
Alcohol consumption
Yes 13 (86.7) 1 (6.7) 1 (6.7) 0 (0.0) 15 (7.0)
No 153 (77.3) 32 (16.2) 5 (2.5) 8 (4.0) 198 (93.0)
χ2=2.424, df=3, P=0.49
History of STI
Yes 20 (87.0) 2 (8.7) 1 (4.3) 0 (0.0) 23 (10.8)
No 146 (76.8) 31 (16.3) 5 (2.6) 8 (4.2) 190 (89.2)
χ2=2.221, df=3, P=0.53
History of STI in spouse
Yes 15 (78.9) 3 (15.8) 1 (5.3) 0 (0.0) 19 (8.9)
No 133 (79.6) 25 (15.0) 3 (1.8) 6 (3.6) 167 (78.4)
I don’t know 18 (66.7) 5 (18.5) 2 (7.4) 2 (7.4) 27 (12.7)
χ2=5.420, df=6, P=0.49
BMI
Chronic energy deficiency 4 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 4 (1.8)
Normal 59 (73.8) 16 (20.0) 2 (2.5) 3 (3.7) 80 (37.6)
Overweight 57 (75.0) 11 (14.5) 3 (3.9) 5 (6.6) 76 (35.7)
Obesity 46 (86.8) 6 (11.3) 1 (1.9) 0 (0.0) 53 (24.9)
χ2=8.996, df=9, P=0.44
*Significant at 5%. BMI=Body mass index, HPV=Human papillomaviruses, STI=Sexually transmitted infection
Table 5: Association between unaided visual inspection of the 
cervix with acetic acid and cytology








Normal 52 (22.2) 15 (32.6) 67 (23.9)
Inflammatory 140 (59.8) 26 (56.5) 166 (59.3)
Mild dysplasia 29 (12.4) 4 (8.7) 33 (11.8)
Moderate dysplasia 5 (2.1) 1 (2.2) 6 (2.1)
Atypical 8 (3.4) 0 (0.0) 8 (2.9)
χ2=3.823, df=4, P=0.43
Pap=Papanicolaou
Table 6: Comparing VIA with cytology
Gold standard (Pap smear) Total
Presence of cervical 
dysplasia
Absence of cervical 
dysplasia
VIA
Presence of acetowhite area 5 41 46
Absence of acetowhite area 42 192 234
Total 47 233 280
VIA=Visual inspection with acetic acid, Pap=Papanicolaou
Mosuro, et al.: Cervical dysplasia and its associated risk factors
Journal of Basic and Clinical Reproductive Sciences · July - December 2015 · Vol 4 · Issue 2 77
clinic in the same center.[5] This corroborated the finding 
of increasing prevalence of cervical dysplasia in women 
especially those in developing countries.
Atypical smear also known as atypical squamous cells of 
uncertain significance in Bethesda classification sometimes 
progress to mild dysplasia over a period of time. Eight (2.9%) 
of the women had atypical cervical smear, these women 
needed to be followed up routinely.
A greater proportion of women with abnormal cervical 
cytology smear were in the 40–49 years age group, with 
dysplasia being the most common in this age group. The 
mean age of the 213 (76.1%) women with abnormal cervical 
cytology was 43.6 ± 11.0 years, and the modal age group 
was 40–49 years. Age is an important factor because the 
chances of a woman developing dysplasia increases with 
increasing age. The mean age for developing dysplasia 
and carcinoma in situ ranged from 34.7 to 38.6 years and 
39.6 to 43.5 years, respectively. Babarinsa et al. in 1998 
found a demonstrable increase in the incidence of cervical 
carcinoma, particularly among women above 30 years of 
age.[36] There was a significant association between age and 
prevalence of abnormal cervical cytology (P = 0.01).
More than four-fifth (81.7%) of the women with abnormal 
cervical cytology were married with greater proportion 
(52.1%) in the monogamous union. The prevalence of 
dysplasia and atypical cells was found to be more in women 
in polygamous union (23.9%) than those in monogamous 
(19.8%) union which support the fact that multiple sexual 
partners in spouse predisposes women to developing 
dysplasia,[34] this was similar to the findings of Adesina and 
Adeniji in the same center.[37]
The majority of the women with abnormal cervical cytology 
smears were living above the poverty line which was 
different from the known association of abnormal cervical 
cytology with poverty.[38]
The decrease in inflammatory cervical cytology with 
increasing educational status could be adduced to an 
improvement in the personal hygiene of woman who had 
formal education. The prevalence of inflammatory cervical 
cytology was found to increase with number of children 
per woman from 57.9% in those who had no child to 83.9% 
in those who had 5 or more children. Furthermore, there 
was an increase in the prevalence of inflammatory cervical 
cytology among women who had STDs (87.0%) than those 
who had never had STDs (76.8%). This could be because 
multiparous women hardly recovers from the effect of 
pregnancy, delivery, and lactation before conceiving again 
and hence tend to have nutritional deficiency of Vitamins A, 
C, E, beta-carotene, and folic acid.[39,40] Studies have shown 
a linear trend in the association between parity and risk of 
developing cervical dysplasia[39] which was not found in this 
study. The number of births is said to be a consistent risk 
factor for cervical dysplasia.[39-41] Parity has been shown to 
increase the risk of cervical cancer by 2.6 in women with 3 
or 4 children and by 3.8 in women with 7 or more children 
than women who had never given birth.[39-41] Another reason 
is the fact that multiparous women tend to marry early and 
have multiple sexual partners or spouses have multiple 
sexual partners hence predisposes them to dysplasia.
A significant association was found between cervical dysplasia 
and HPV in this study, this had also been reported in several 
studies including that of Thomas et al. in 2004, in Ibadan,[42] 
and Schiffman et al. in 1993,[43] International Agency for 
Research on Cancer in 1995[6] and Bosch et al. in 1995.[7]
The prevalence of dysplasia and atypical cells among women 
who had sexual intercourse before 18 years (21.7%) and 
those who had after 18 years (22.3%) were similar. Sexual 
exposure before the age of 18 years is said to predispose 
to cervical dysplasia because women who were exposed to 
sexual intercourse early have a greater tendency to having 
multiple sexual partners which predisposes them to HPV 
infection.[18,44,45]
More women who had used oral contraceptive pills 18 (25.0%) 
had a greater prevalence of cervical dysplasia and atypical 
smear than those who had never used oral contraceptive 
pills 29 (20.6%). This support the documentation that 
long-term use (for 12 years or more) of oral contraceptive 
predisposes a woman to cervical dysplasia[46] though this 
was found not to be statistically significant. Ursin et al. in 
1994 found adenocarcinoma to be twice as common in 
women who used oral contraceptives than those who did 
not use it.[46] Brinton in 1990 indicated that the use of oral 
contraceptives and the duration of their use appear to 
increase the risk and subsequent development of cervical 
dysplasia and cancer.[47] However, study done in New Zealand 
showed that confounding factors such as cigarette smoking 
and sexual behavior were responsible for cervical dysplasia, 
as analysis revealed no evidence of increased risk to cervical 
dysplasia when these factors were taken into account.[48]
Visual inspection of the cervix with 5% acetic acid had 
similar prevalence 16.4% as Pap smear 16.8%. But had low 
sensitivity (10.6%) and specificity (82.4%) compared with Pap 
smear sensitivity (51%) and specificity (98%). This was similar 
to findings by Omigbodun et al. and Akinwuntan et al. in 
the same institution who stated that VIA is a highly specific 
method for detecting dysplasia.[49] These findings buttress 
WHO suggestion that VIA could be used for mass screening 
in low-resource countries like Nigeria to reduce the burden 
of cervical cancer.[5,50]
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Although the sensitivity and specificity of VIA were found to 
be low, it could still be used as an alternative to Pap smear 
for mass screening of women in low-resource countries like 
Nigeria. This will go a long way to reduce the incidence 
of cervical cancer in these countries since most of these 
women do not have access to Pap smear facilities which in 
most instances are provided only in tertiary hospitals.
The increase in cervical cancer awareness in this study over 
that found by Ajayi and Adewole in the same clinic in 1998 
emphasized the importance of health education in the 
cervical cancer prevention program.[14]
As with any hospital-based studies, the limitations of this 
study were financial constraint limiting the number of 
subjects recruited for the study and also the prevalence of 
cervical dysplasia and associated risk factors identified may 
not fully represent those in the community.
CONCLUSION
Cervical dysplasia is a significant problem among women 
attending the GOP Clinic. This underscores the need for the 
provision of screening service at the clinic and effective health 
education to promote preventive practices and inculcate 
screening culture among women. Since VIA was found to be 
specific for detecting high-grade lesions, it could serve as an 
alternative to cytology in low-resource countries like Nigeria 
hence make screening for cervical dysplasia available to all 
women at an affordable cost. However, advocacy should be 
made to make Pap smear which is a superior screening test 
more accessible and affordable to women.
From this study, the following recommendations are made:
•	 Establishing	a	screening	facility	at	GOP	Clinic	to	make	
access easy for the women seen in this clinic
•	 Importance	 of	 routine	 cervical	 cancer	 screening	
should always be mentioned to every sexually active 
woman in health education talk given to women in the 
clinics. All sexually active women should, therefore, 
be encouraged to do routine cervical cancer screening 
at least once in their lifetime. The public should also 
be enlightened about cervical cancer and importance 
of routine screening to reduce the burden of cervical 
cancer on individual, family, and community
•	 All	 primary	 health	 care	 and	 family	 physicians	 should	
endeavor to learn how to screen women for cervical 
dysplasia. They must, therefore, offer cervical cancer 
screening routinely to all the women attending their 
clinic as an office procedure and make the result 
available in the shortest possible time
•	 Government	should	make	protocols	for	routine	cervical	
cancer screening and make facilities available even at 
grassroot level so that all women would have access to 
effective screening
•	 Visual	inspection	of	the	cervix	with	acetic	acid	should	not	
be a substitute for Pap smear; as such cytotechnologists 
should be trained to reduce the burden on the Pathologists
•	 Awareness	 campaign	 about	 cervical	 dysplasia	 and	
cancer should be embarked upon in our communities 
to improve utilization of screening facilities available 
which could be achieved through our media houses.
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